These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38 related articles for article (PubMed ID: 1480736)
1. The convergent validity of the Drug Impairment Rating Scale for Cocaine. Halikas JA; Crosby RD; Nugent SM Psychopharmacol Bull; 1992; 28(3):315-8. PubMed ID: 1480736 [TBL] [Abstract][Full Text] [Related]
2. Measuring outcome in the treatment of cocaine abuse: the Drug Impairment Rating Scale for cocaine. Halikas JA; Crosby RD J Addict Dis; 1991; 11(2):121-38. PubMed ID: 1811758 [TBL] [Abstract][Full Text] [Related]
3. Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208 [TBL] [Abstract][Full Text] [Related]
4. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920 [TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse. Halikas JA; Crosby RD; Pearson VL; Graves NM Clin Pharmacol Ther; 1997 Jul; 62(1):89-105. PubMed ID: 9246023 [TBL] [Abstract][Full Text] [Related]
6. Phenytoin in the treatment of cocaine abuse: a double-blind study. Crosby RD; Pearson VL; Eller C; Winegarden T; Graves NL Clin Pharmacol Ther; 1996 Apr; 59(4):458-68. PubMed ID: 8612392 [TBL] [Abstract][Full Text] [Related]
7. A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency. Jenkins SW; Warfield NA; Blaine JD; Cornish J; Ling W; Rosen MI; Urschel H; Wesson D; Ziedonis D Psychopharmacol Bull; 1992; 28(1):21-6. PubMed ID: 1609038 [TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence. Brown ES; Gorman AR; Hynan LS J Clin Psychopharmacol; 2007 Oct; 27(5):498-502. PubMed ID: 17873684 [TBL] [Abstract][Full Text] [Related]
9. [Relationships between insight and medication adherence in subjects with psychosis]. Droulout T; Liraud F; Verdoux H Encephale; 2003; 29(5):430-7. PubMed ID: 14615692 [TBL] [Abstract][Full Text] [Related]
10. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Ziedonis DM; Kosten TR Psychopharmacol Bull; 1991; 27(3):337-43. PubMed ID: 1775608 [TBL] [Abstract][Full Text] [Related]
11. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385 [TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder. Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552 [TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment among the dually-diagnosed: substance use history and depressive symptom correlates. Carpenter KM; Hittner JB Addiction; 1997 Jun; 92(6):747-59. PubMed ID: 9246802 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124 [TBL] [Abstract][Full Text] [Related]
15. Mazindol treatment of cocaine abuse. A double-blind investigation. Diakogiannis IA; Steinberg M; Kosten TR NIDA Res Monogr; 1990; 105():514. PubMed ID: 1876105 [No Abstract] [Full Text] [Related]
16. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania. Eden Evins A; Demopulos C; Nierenberg A; Culhane MA; Eisner L; Sachs G Bipolar Disord; 2006 Feb; 8(1):75-80. PubMed ID: 16411983 [TBL] [Abstract][Full Text] [Related]
17. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292 [TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831 [TBL] [Abstract][Full Text] [Related]
19. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. Brady KT; Sonne SC; Anton R; Ballenger JC J Clin Psychiatry; 1995 Mar; 56(3):118-21. PubMed ID: 7883730 [TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]